Suppr超能文献

基于心率变异性相关特性检测慢性心力衰竭患者的运动强度阈值

Detection of exercise intensity thresholds in patients with chronic heart failure based on correlation properties of heart rate variability.

作者信息

Sempere-Ruiz Noemí, Manresa-Rocamora Agustín, Fuertes-Kenneally Laura, Sanz-Rocher Ana, Baladzhaeva Sabina, Climent-Payá Vicente, Moya-Ramón Manuel, Sarabia José M

机构信息

Department of Sport Sciences, Sports Research Centre, Miguel Hernández University of Elche, 03202, Elche, Spain.

Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010, Alicante, Spain.

出版信息

Eur J Appl Physiol. 2025 Jun 25. doi: 10.1007/s00421-025-05860-9.

Abstract

PURPOSE

This study aimed to assess the agreement between ventilatory thresholds (VT1 and VT2), and heart rate variability (HRV) thresholds (HRVT1 and HRVT2) based on the alpha 1 index of detrended fluctuation analysis (DFA a1) in patients with chronic heart failure (CHF). Validating HRV-based thresholds could provide a cost-effective alternative for individualised exercise intensity prescription, improving safety and efficacy in exercise-based cardiac rehabilitation (CR) programmes.

METHODS

Twenty CHF patients (13 males, 7 females) performed a cardiopulmonary exercise test (CPET) on a cycle ergometer. Ventilatory thresholds were identified using a mixed method, while HRV thresholds were determined at DFA a1 values of 0.75 (HRVT1) and 0.5 (HRVT2). Threshold values for oxygen consumption (VO), heart rate (HR), and power output (PO) were compared with paired t test or Wilcoxon test. Agreement was assessed using correlation coefficients (Pearson's r and Spearman's rho), intraclass correlation coefficient (ICC), and Bland-Altman analysis.

RESULTS

HRVT2 showed moderate-to-strong associations with VT2 for VO (rho = 0.88, ICC = 0.86), for HR (r = 0.88, ICC = 0.81) and for PO (r = 0.82, ICC = 0.85). Mean biases were small and limits of agreement (LoA) narrow. HRVT1 correlated only modestly with VT1 for VO (rho = 0.67, ICC = 0.43) and weakly for HR (r = 0.43, ICC = 0.37) and PO (r = 0.49, ICC = 0.35), with wide LoA.

CONCLUSION

In CHF patients, HRVT2 appears to be a valid, practical surrogate for VT2 and may facilitate personalised intensity prescription where full CPET is unavailable. HRVT1 showed insufficient agreement with VT1 and should be used with caution. Larger cohorts and protocol refinements are warranted to confirm these observations and to explore strategies for improving HRVT1 accuracy.

摘要

目的

本研究旨在评估慢性心力衰竭(CHF)患者中基于去趋势波动分析(DFA)的α1指数的通气阈值(VT1和VT2)与心率变异性(HRV)阈值(HRVT1和HRVT2)之间的一致性。验证基于HRV的阈值可为个体化运动强度处方提供一种经济有效的替代方法,提高基于运动的心脏康复(CR)计划的安全性和有效性。

方法

20例CHF患者(13例男性,7例女性)在自行车测力计上进行了心肺运动试验(CPET)。使用混合方法确定通气阈值,而HRV阈值则在DFA的α1值为0.75(HRVT1)和0.5(HRVT2)时确定。使用配对t检验或Wilcoxon检验比较耗氧量(VO)、心率(HR)和功率输出(PO)的阈值。使用相关系数(Pearson相关系数r和Spearman秩相关系数rho)、组内相关系数(ICC)和Bland-Altman分析评估一致性。

结果

HRVT2与VT2在VO方面显示出中度至强的相关性(rho = 0.88,ICC = 0.86),在HR方面(r = 0.88,ICC = 0.81)以及在PO方面(r = 0.82,ICC = 0.85)。平均偏差较小且一致性界限(LoA)较窄。HRVT1与VT1在VO方面仅呈中度相关(rho = 0.67,ICC = 0.43),在HR方面呈弱相关(r = 0.43,ICC = 0.37),在PO方面呈弱相关(r = 0.49,ICC = 0.35),且LoA较宽。

结论

在CHF患者中,HRVT2似乎是VT2的有效、实用替代指标,并且在无法进行完整CPET的情况下可能有助于个体化强度处方。HRVT1与VT1的一致性不足,应谨慎使用。需要更大的队列研究和方案改进来证实这些观察结果,并探索提高HRVT1准确性的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验